Drug(s) with the following simplified MOA: principle androgen responsible for promoting growth of male sex organs; forms a hormone-receptor complex
Testosterone
64
New cards
Drug(s) with the following simplified MOA: steroid hormone that induces secretory changes in endometrium, relaxes uterine smooth muscle, blocks follicular maturation and ovulation, and maintains pregnancy
Progesterone
65
New cards
Drug(s) with the following simplified MOA: responsible for development and maintenance of female reproductive system; modulates pituitary secretion of gonadotropins, LH, and FSH
Estradiol (oral, topical, vaginal)
66
New cards
Drug(s) with the following simplified MOA: inhibits ovulation via a negative feedback mechanism which alters gonadotropin secretion of FSH and LH; alters cervical mucus
Drug(s) with the following simplified MOA: inhibits aromatase in order to block conversion of androstenedione to estrone, and testosterone to estradiol which decreases tumor mass and delays cancer progression
Anastrozole
68
New cards
Simplified ADR list for Testosterone
increased PSA, lipid changes, polycythemia
69
New cards
Simplified ADR list for Progesterone
weight change, headache, amenorrhea, breast tenderness, abdominal pain
70
New cards
Simplified ADR list for Estradiol (oral, topical, vaginal)
weight change, N/V, breast tenderness, mood change; rare- thromboembolic events, heart disease, breast/endometrial/ovarian cancer
71
New cards
Simplified ADR list for Ethinyl estradiol/etonogestrel
vaginitis, headache, menstrual irregularities, breast tenderness; rare- thromboembolic events
72
New cards
Simplified ADR list for Ethinyl estradiol/norethindrone
nausea, headache, menstrual irregularities, breast tenderness; rare- thromboembolic events
73
New cards
Simplified ADR list for Ethinyl estradiol/norgestimate
nausea, headache, menstrual irregularities, breast tenderness; rare- thromboembolic events